Immunobiology

Dopexamine and cellular immune functions during systemic inflammation
pp. 429-438(10)
Authors: Oberbeck R.; Schmitz D.; Schüler M.; Wilsenack K.; Schedlowski M.; Exton M.

Ubiquitin-like polypeptide inhibits cAMP-induced p38 MAPK activation in Th2 cells
pp. 439-444(6)
Authors: Nakamura M.; Tanigawa Y.

Bacterial lipopolysaccharide induces proliferation of IL-6-dependent plasmacytoma cells by MAPK pathway activation
pp. 445-454(10)
Authors: Iankov I.; Atanasova G.; Praskova M.; Kalenderova S.; Petrov a.; Mitev V.; Mitov I.

Lymphocyte subpopulations from patients with primary antibody deficiency do not show increased telomere erosion
pp. 455-462(8)
Authors: Tucker V.C.; Rye A.D.; Harrison J.; King L.; Duddridge M.; Browning M.J.

Elimination of activated but not resting primary human CD4⁺ and CD8⁺ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells
pp. 463-475(13)
Authors: Hoves S.; Krause S.W.; Herfarth H.; Halbritter D.; Zhang H-G.; Mountz J.D.; Schölmerich J.; Fleck M.